
|Videos|September 13, 2022
Cate Lockhart Presents on the Uptake of Biosimilars at PBMI 2022
Author(s)Briana Contreras
Cate Lockhart, MS, PharmD, PhD, Executive Director at the Biologics and Biosimilars Collective Intelligence Consortium covers her presentation "New mAbs on the Block: A Rocking Research Update on Biosimilar Uptake and Benefit Design" which she delivered at this year's PBMI national conference.
Advertisement
Cate Lockhart, MS, PharmD, PhD, Executive Director at the Biologics and Biosimilars Collective Intelligence Consortium covers her presentation "New mAbs on the Block: A Rocking Research Update on Biosimilar Uptake and Benefit Design" which she delivered at this year's PBMI national conference.
Advertisement
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
CVS Caremark to put Zepbound back on formulary and add Foundayo
2
Carveouts in healthcare safety net reform risk empowering middlemen
3
Eli Lilly acquires three vaccine companies for infectious disease portfolio
4
A Milestone in Vitiligo: Clinical Efficacy and Long-Term Repigmentation Trends
5




























